Omnia Education: Exclusively Women’s Health Education - Omnia Education

Exclusively Women’s Health Education

Exclusively Women’s Health Education

Enhance your practice with CME
and tools that focus on diseases and
conditions impacting the female patient.

Popular

From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
MinuteCE®
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
Aditya Bardia, MD, MPH, FASCO; Erica L. Mayer, MD, MPH
0.50 program credits
- Aditya Bardia, MD, MPH, FASCO
- Erica L. Mayer, MD, MPH
0.50 program credits
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
MinuteCE®
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Erica L. Mayer, MD, MPH
0.50 program credits
- Erica L. Mayer, MD, MPH
0.50 program credits
MinuteCE®
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO; Erica L. Mayer, MD, MPH
0.50 credits 4 episodes
- Aditya Bardia, MD, MPH, FASCO
- Erica L. Mayer, MD, MPH
0.50 credits 4 episodes
Escalate With Intention: Stepwise, Target-Anchored Moves
Escalate With Intention: Stepwise, Target-Anchored Moves
MinuteCE®
Escalate With Intention: Stepwise, Target-Anchored Moves
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
Shared Goals, Shared Gains: Align With Patient Preferences
Shared Goals, Shared Gains: Align With Patient Preferences
MinuteCE®
Shared Goals, Shared Gains: Align With Patient Preferences
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
MinuteCE®
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 credit 10 episodes
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 credit 10 episodes
When to Begin FcRn: Initiation Criteria, Key Evidence
When to Begin FcRn: Initiation Criteria, Key Evidence
MinuteCE®
When to Begin FcRn: Initiation Criteria, Key Evidence
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
Turning Flares Into Function: Flag Uncontrolled Disease
Turning Flares Into Function: Flag Uncontrolled Disease
MinuteCE®
Turning Flares Into Function: Flag Uncontrolled Disease
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit

CME/CE

Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
MinuteCE®
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Christyn Edmundson, MD
1.00 program credit
- Christyn Edmundson, MD
1.00 program credit
FcRn: Same Class, Different Paths—Spot Agent Differentiators
FcRn: Same Class, Different Paths—Spot Agent Differentiators
MinuteCE®
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
Minimal By Design: Define MSE Endpoints
Minimal By Design: Define MSE Endpoints
MinuteCE®
Minimal By Design: Define MSE Endpoints
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
CME/CE
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Kenneth J. Moise Jr., MD; Kara B. Markham, MD
0.25 credits
- Kenneth J. Moise Jr., MD
- Kara B. Markham, MD
0.25 credits
ENDOVOICE Live: Endometriosis—A Chronic Burden of Reproductive Years
ENDOVOICE Live: Endometriosis—A Chronic Burden of Reproductive Years
CME/CE Broadcast Replay
ENDOVOICE Live: Endometriosis—A Chronic Burden of Reproductive Years
Linda Bradley, MD; Obianuju Sandra Madueke-Laveaux, MD, MPH
1.00 credit
- Linda Bradley, MD
- Obianuju Sandra Madueke-Laveaux, MD, MPH
- Lauren R. Kornegay
1.00 credit
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
CME/CE Broadcast Replay
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
Gideon Hirschfield, MB, BChir, PhD; Marlyn Mayo, MD
1.00 credit
- Gideon Hirschfield, MB, BChir, PhD
- Marlyn Mayo, MD
1.00 credit
Diagnosing and Treating IBS: It Begins With One Simple Question
Diagnosing and Treating IBS: It Begins With One Simple Question
CME/CE Broadcast Replay
Diagnosing and Treating IBS: It Begins With One Simple Question
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE; Kimberly D. Orleck, PA-C
1.00 credit
- Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
- Kimberly D. Orleck, PA-C
1.00 credit
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
CME/CE Broadcast Replay
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
Alison Kole, MD, MPH, FACCP; Ghada Bourjeily, MD, FCCP
1.00 credit
- Alison Kole, MD, MPH, FACCP
- Ghada Bourjeily, MD, FCCP
- Rashmi Nisha Aurora, MD
- Audrey Wells, MD
1.00 credit

Clinical Practice

Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
MinuteCE®
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO
0.50 program credits
- Aditya Bardia, MD, MPH, FASCO
0.50 program credits
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
MinuteCE®
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
0.50 program credits
- Aditya Bardia, MD, MPH, FASCO
0.50 program credits
The 2-Point Signal: Apply ≥2-Point Rule
The 2-Point Signal: Apply ≥2-Point Rule
MinuteCE®
The 2-Point Signal: Apply ≥2-Point Rule
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
Target Locked in gMG: Why T2T Matters
Target Locked in gMG: Why T2T Matters
MinuteCE®
Target Locked in gMG: Why T2T Matters
Christyn Edmundson, MD; Gil I. Wolfe MD, FAAN
1.00 program credit
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credit
Not Just a Headache: Migraine Across Women’s Lifespan
Not Just a Headache: Migraine Across Women’s Lifespan
CME/CE Broadcast Replay
Not Just a Headache: Migraine Across Women’s Lifespan
Jelena Pavlović, MD, PhD; Amaal J. Starling, MD, FAHS, FAAN
1.00 credit
- Jelena Pavlović, MD, PhD
- Amaal J. Starling, MD, FAHS, FAAN
1.00 credit
The Alloimmune Disorders of Pregnancy
The Alloimmune Disorders of Pregnancy
MinuteCE®
The Alloimmune Disorders of Pregnancy
Karin J. Blakemore, MD; Emilie L. Vander Haar
1.00 program credit
- Karin J. Blakemore, MD
- Emilie L. Vander Haar
1.00 program credit
Clinical Considerations for the Diagnosis of Endometriosis
Clinical Considerations for the Diagnosis of Endometriosis
MinuteCE®
Clinical Considerations for the Diagnosis of Endometriosis
Linda Bradley, MD; James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
- Linda Bradley, MD
- James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Strategies to Address Healthcare Disparities in Patients With Endometriosis
MinuteCE®
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Linda Bradley, MD; Melissa Simon, MD
1.75 program credits
- Linda Bradley, MD
- Melissa Simon, MD
1.75 program credits

Programs

CME/CE In-Person Event
22nd Annual Women’s Health Annual Visit (WHAV)
December 04, 2026
New York, New York
6.00 credits
MinuteCE®
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Karin J. Blakemore, MD; Emilie L. Vander Haar
1.00 credit 10 episodes
- Karin J. Blakemore, MD
- Emilie L. Vander Haar
1.00 credit 10 episodes
MinuteCE®
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Lee P. Shulman, MD, FACMG, FACOG; Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
1.75 credits 10 episodes
- Lee P. Shulman, MD, FACMG, FACOG
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- Sawsan As-Sanie, MD
- Linda Bradley, MD
- James A. Simon, MD, CCD, NCMP, IF, FACOG
- Melissa Simon, MD
- Samantha Denäe
- Casey Joe Hinds
1.75 credits 10 episodes
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
MinuteCE®
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP; James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
MinuteCE®
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP; Sawsan As-Sanie, MD
1.75 program credits
- Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
- Sawsan As-Sanie, MD
- James A. Simon, MD, CCD, NCMP, IF, FACOG
1.75 program credits
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
CME/CE
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Lee P. Shulman, MD, FACMG, FACOG; Roberto Romero, MD, DMedSci
- Lee P. Shulman, MD, FACMG, FACOG
- Roberto Romero, MD, DMedSci
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
CME/CE
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
Lee P. Shulman, MD, FACMG, FACOG; Alexandra Benachi, MD, PhD
- Lee P. Shulman, MD, FACMG, FACOG
- Alexandra Benachi, MD, PhD
- Julien Zuber, MD, PhD
Alloimmune Neutropenia of the Fetus and Newborn
Alloimmune Neutropenia of the Fetus and Newborn
CME/CE
Alloimmune Neutropenia of the Fetus and Newborn
Lee P. Shulman, MD, FACMG, FACOG; Masja de Haas, MD, PhD
- Lee P. Shulman, MD, FACMG, FACOG
- Masja de Haas, MD, PhD